Virulent group A streptococci have been found to express a cell-surface factor that has the capability of inactivating complement-derived chemotactic factors. To determine the mechanism ofaction ofthis factor, we examined the interaction of purified inactivator with pure C5a chemotaxin. Ligand-receptor binding studies demonstrated that streptococcal chemotactic factor inactivator (SCFI)-treated C5a expressed a greatly reduced ability to bind to receptors of polymorphonuclear leukocytes as compared with native C5a.
The inactivation of C5a occurred by a nonstoichiometric and temperature-dependent process. NaDodSO4/PAGE analysis indicated that SCFI mediated a small decrease in the molecular weight of C5adArg, and sequencing of the carboxyl terminus of inactivated C5a demonstrated that a six-residue peptide was lost. The release of discrete peptide fragments from denatured bovine serum albumin upon prolonged incubation with SCFI was indicative of endoprotease activity. Although denatured bovine serum albumin was inefficiently cleaved, native bovine serum albumin and other native proteins were highly resistant to SCFI proteolysis; this indicated that activity was specific in nature.
The acute inflammatory response represents an immediate reaction ofhost tissues and, therefore, the first line ofdefense to invading microorganisms. Activation of the alternative (antibody-independent) complement system by components of the microbial cell surface serves the host as a recognition event to signal the occurrence of an invasion. This activation is characterized by the formation of fluid-phase C5a and C3a anaphylatoxins, both of which stimulate smooth muscle contraction, increase vascular permeability, and trigger degranulation and release of histamine from mast cells and basophils (1) . Furthermore, C5a is a potent stimulant for phagocytic leukocytes, inducing a burst of metabolic activity (2, 3) , release of toxic superoxide radicals (4) , and release of lysosomal enzymes (5, 6) . In the form of a concentration gradient, it also provides a chemotactic signal. CSa is the major chemoattractant generated in serum after activation of complement (7) , and in many situations it is responsible for the rapid neutrophilic infiltration at inflammatory loci (8) .
There are three major strategies by which the complementrelated chemotactic response can be reduced or prevented in host-parasite interactions: (i) the inhibition of complement activation, (ii) secretion of toxins that suppress cellular responsiveness to chemotactic stimuli, and (iii) inactivation of generated chemotaxins. Until recently, evidence for inactivation of complement-derived chemotactic factors has been scant. While bacterial proteases from Serratia marcescens, group A streptococci, and Pseudomonas aeruginosa have been characterized that have this activity (9, 10), they are nonspecific, readily attacking a variety of protein substrates. In addition, prolonged incubations are required for chemotactic activity to be reduced. The lack of specificity of these enzymes is further exemplified by the generation of chemotactic fragments from native C5 (9, 10), a phenomenon that would appear counterproductive in terms of phagocyte evasion.
We have previously reported on the ability of virulent group A streptococci to inactivate complement-derived chemotactic activity via an uncharacterized cell-surface molecule that was distinguished from the virulence marker, M protein (11) . This factor has since been purified and was found to be an acidic high molecular weight protein antigen (28) . We have provisionally designated this antigen the streptococcal chemotactic factor inactivator (SCFI) on the basis of its anti-chemotactic activity. In this report, we describe our investigations into the mechanism by which SCFI inhibits the biologic activity of C5a.
MATERIALS AND METHODS
Isolation of SCFI. SCFI was extracted from M49 T14 group A streptococci by a limited trypsin digestion and was purified by hydrophobic interaction chromatography, anion-exchange chromatography, and gel filtration (28) . Hyperimmune antiserum to SCFI was produced by repeated injection of rabbits with the purified protein emulsified in Freund's adjuvant (12) , and the content of specific antibody was determined by immunodiffusion and neutralization of SCFI activity.
Preparation of Human C5a and C5adA. C5a was generated in zymosan-activated human serum containing 1 M e-aminocaproic acid and it was purified according to the procedure of Fernandez and Hugli (13) . CSa&esArg was purified by the same method except that serum was activated in the absence of E-aminocaproic acid. Human C5a was radiolabeled with Na125I (Amersham) by the solid-phase lactoperoxidase/glucose oxidase method as described (14) . 125I1 labeled COadesArg for analysis by NaDodSO4/PAGE analysis was obtained from Upjohn.
Purification of SCFI-Inactivated C5a. C5 (10 nmol) was mixed with 20 ,g of SCFI in phosphate-buffered saline/1% bovine serum albumin, pH 7.4, and incubated for 2 hr at 37°C. The reaction mixture was applied to a 1.0-ml anti-C5a immunoaffinity column previously prepared by conjugating murine anti-COa IgG with cyanogen bromide-activated Sepharose 4B. After washing with 0.1 M P04/0.5 M NaCl, pH 7.8, the bound C5a antigen was subsequently eluted with 30% (vol/vol) acetic acid, pooled, and lyophilized.
Preparation of Human Peripheral Polymorphonuclear Leukocytes (PMNs). Human PMNs were collected by venipuncture of healthy volunteers as described by Boyum (15) . After Ficoll-Hypaque centrifugation (16) , the PMN-containing layer was subjected to hypotonic lysis in 0.87% NH4Cl to remove contaminating erythrocytes (17) . The PMNs were harvested by centrifugation at 150 x g for 10 min, washed twice in 0.9% NaCl, and resuspended to the appropriate cell Abbreviations: SCFI, streptococcal chemotactic factor inactivator; PMN, polymorphonuclear leukocyte.
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C5a Binding Assay. Binding of 125I-labeled C5a to PMNs was assessed by mixing 4 x 106 PMNs per ml in RPMI medium/1% bovine serum albumin with 125I-labeled CSa at a final concentration of 1 nM in a 0.1-ml vol. The mixtures were incubated for 15 min at 240C in 1.5-ml conical polypropylene microfuge tubes followed by centrifugation at 11,000 x g for 30 sec in a Beckman Microfuge B. The amount of cell-bound 125I-labeled C5a was determined by transferring one-half of the PMN-free supernatant to a separate tube and comparing the y radioactivity of the paired samples P (pelleted cells + one-half supernatant) and S (one-half supernatant). Cellbound 1251-labeled C5a was calculated according to the following equation:
% bound = cpm(S + P) -NS cpm(S) x 100.
cpm(S + P) NS, nonspecific binding to the assay tube, was cpm(P + S)/cpm(S). Of the total ligand, 30-50%o was PMN-associated under these conditions (18) .
Radioimmunoassay for Human C5a. Quantitation of CSa antigen was achieved with radioimmunoassay procedures as described (18 were generated with native CSa (1-100 nM) serving as the competing antigen.
Amino Acid Analysis. For determination of free amino acids, unhydrolyzed samples or 2 nmol of hydrolyzed C5a standard were examined by using a Durrum amino acid analyzer. Hydrolysis of C5a was done in 5.6 M HCl by heating in a vacuum-sealed ampoule at 100°C for 18 hr.
Carboxyl-Terminal Analysis. C5ad,,svg (1 nmol) or purified SCFI-inactivated CSa in 0.1 M NH4HCO3 (pH 8.15) was digested with 0.1 nmol of carboxypeptidase A (phenylmethylsulfonyl fluoride-treated) (Worthington) and 0.1 nmol of carboxypeptidase B (Calbiochem) for 4.5 hr at 37°C (19) . These samples were lyophilized and analyzed for free amino acids in the absence of hydrolysis as described above. NaDodSO4/PAGE. Discontinuous polyacrylamide gel electrophoresis was carried out under reducing conditions by a modification of the procedure of Laemmli (20) . For electrophoresis of 1251-labeled C5adsArg, a separation gel was used consisting of an exponential gradient of 15-20% acrylamide (12-16% glycerol) and radiolabeled protein visualized by autoradiography with Kodak XAR-5 x-ray film. Denatured bovine serum albumin was prepared by a modification of the alkaline urea method of Anson (21) . Bovine serum albumin (50 pAg) in H20 was first incubated with 50 mM dithiothreitol for 10 min at room temperature, then the protein was alkalinized with NaOH (0.08 M final NaOH concentration). Crystalline urea was added to 7.3 M, and the mixture was incubated at room temperature for 1 hr. The denatured bovine serum albumin was diluted with an equal volume of 0.062 M Tris HCl (pH 7.4) and dialyzed overnight against the same buffer. A 5-15% acrylamide gradient was used for electrophoresis of bovine serum albumin (Sigma), and silver staining was by the Oakley method (22).
RESULTS
Inactivation of 12'I-Labeled C5a by SCFI. While SCFI could clearly inhibit the chemotactic activity of zymosan-activated human serum (11) , it remained to be determined whether purified C5a could be similarly inactivated. To examine this, the concentration-dependent effect of SCFI on the PMN receptor binding and antigenic properties of 1III-labeled C5a was assessed. SCFI, ranging in concentration from 0 to 625 ng/ml, was incubated with 5 nM "2'I-labeled C5a (41 ng/ml) for 60 min at 37°C, and the ability of treated ligand to bind PMNs was measured. As shown in Fig. 1, specific PMN binding of "25I-labeled C5a was completely inhibited by prior incubation of the ligand with SCFI (10 ng/ml), and as little as 0.07 ng of SCFI per ml produced a significant binding inhibition. The possibility that this effect was due to the complete destruction of CSa by either SCFI or enzymatic contaminants of the SCFI preparation was highly unlikely because the antigenicity of the 1251-labeled CSa remained unaltered (Fig. 1) .
Comparison Temperature Dependency of C5a Inactivation. Fig. 1 suggested that SCFI was acting as an enzyme. To support this hypothesis, we examined the temperature dependency of the rate of C5a inactivation. The rate of reaction was defined at 40C, 240C, and 370C; each reaction terminated by addition of SCFI antiserum to neutralize SCFI activity. The results in Fig. 3 demonstrate that the rate of inactivation of 125I-labeled C5a was clearly dependent on the incubation temperature. After 60 min, there was complete inactivation only at 370C, with -90% inactivation at 240C and 50% inactivation at 40C.
Proteolytic Cleavage of C5a by SCFI. NaDodSO4/PAGE analysis was performed to determine whether inactivation of 125I-labeled COadesArg by SCFI was accompanied by a decrease in molecular weight, as would be expected from enzymatic cleavage of the molecule. As shown in Fig. 4 (19) . Because the sequence of C5a is known, this approach will unequivocally identify the COOHterminal residue. The results presented in Table 1 demonstrate that SCFI-inactivated C5a lacks the end sequence -Asp69-Met70-Gln71-Leu72-Gly73-Arg74 (23) , and therefore C5a cleavage occurs between Lys' and Asp69. The detection of the amino acids phenylalanine, tyrosine, and threonine is not compatible with the known sequence of C5a. The aberrant release of phenylalanine and tyrosine could in part be the result of contamination of the carboxypeptidases with a chymotryptic-like activity. In addition, it is necessary to postulate additional contaminants in the SCFI-C5adsAg mixture in order to account for the release of a relatively high concentration of threonine. Alternatively, the immunoaffinity-purified C5adeACg could have contained a small fraction of partially degraded molecules. The relative yield of these amino acids does not allow us to conclude which component was contaminated; nevertheless, this does not detract from the conclusion that one COOH terminus predominated in each preparation.
Endoprotease Activity of SCFI. The possibility that an exopeptidase activity of SCFI participated in the cleavage of C5a was examined. A reaction mixture containing 2 nmol of C5a and 4 Ag of SCFI was tested for the appearance of free amino acids by automated amino acid analysis. SCFI was analyzed separately as a control for background amino acids, and acid-hydrolyzed C5a served as the amino acid standard.
No amino acids above control levels were detected in this mixture, suggesting that CSa was not degraded by SCFI through an exopeptidase function. In addition, a small basic peak was detected by the amino acid analyzer that did not correspond with the C5a amino acid standards; this most likely represented a short peptide derived from the CSa. FIG. 5 . Proteolytic activity of SCFI with bovine serum albumin as the substrate. Bovine serum albumin (80 ,g/ml) (A) or ureadenatured bovine serum albumin (B) was incubated in 0.0625 M Tris HCl (pH 7.4) with SCFI (20 pg/ml) at 37°C. Aliquots (10 ,A) were removed at various time points, boiled with sample buffer, and analyzed by NaDodSO4/PAGE. The gel consisted of a 5-15% acrylamide gradient, and proteins were stained by the silver technique. BSA, denatured bovine serum albumin at 48 hr (lanes 1); SCFI at 48 hr (lanes 2); bovine serum albumin at appearing within 1 hr (Fig. 5B) . The appearance of discrete peptide fragments on prolonged incubation is characteristic of endoproteolytic cleavage. Other proteins tested for SCFI sensitivity were highly resistant in the native state, including human serum albumin, ovalbumin, soybean trypsin inhibitor, carbonic anhydrase, a-lactalbumin, myosin, and cytochrome c. As with bovine serum albumin, several showed a slight increase in lability to SCFI after prior denaturation with urea.
DISCUSSION
The truncation of the carboxyl end of C5a has been shown previously to reduce the ability of the molecule to stimulate the leukocyte functions of chemotaxis and exocytosis (3, 24) , which are involved in the development of inflammation and a microbicidal environment in the vicinity of complementactivating microorganisms. This loss of C5a functional activity is due at least in part to a reduced binding affinity for the CSa receptors ofPMNs (25) . After complement activation in serum, the C5a that is generated is immediately attacked by an endogenous carboxypeptidase B-like enzyme (carboxypeptidase N) that specifically removes the COOH-terminal arginine residue to form the derivative, C5ad,,km (26) . This results in the essentially complete loss of intrinsic spasmogenic and vascular permeability-increasing properties (26) as well as a decrease by a factor of 10-20 in the ability to promote leukocyte functions (25) . The complete conversion of C5a to C5adfSq is consistent on a quantitative basis with the C5-related chemotactic activity found in zymosan-activated serum (25) , and this conversion probably serves to limit the tissue-destructive effects of C5a-induced inflammation (27) . The sequential removal offive amino acids from the carboxyl-terminal end of C5a with yeast carboxypeptidase Y to form the analogue C5a-(1-69) results in the complete loss of functional activity and a parallel, although incomplete, reduction in binding affinity (25) . The significant residual binding capacity of C5a-(1-69) has led to the proposal that the carboxyl-terminal region provides an essential receptor recognition function auxiliary to the internal portion of the ligand, as well as an "activation" site required for the stimulation of receptor-mediated functions (25) .
The results of the present study show that SCFI is a protease that attacks the COOH-terminal region of C5a at the carboxyl side of a lysine residue to produce a molecule that lacks the capacity for functional interaction with PMN (8) . Such a temporal inhibition in the mounting of phagocytic defenses could shift the balance of survival in favor of establishment of the organism through multiplication to a critical colony size or the securing of a more favorable microenvironment for growth. The failure to detect significant quantities of secretory SCFI, as well as its extractability from cells presumed to be intact, suggests an external or cell wall-bound location (11) . Hypothetically, this location would be likely to provide a concentrated and immediate access of the enzyme to sites of C5a generation at the bacterial surface and would, therefore, be effective in situations providing for the rapid dilution of secreted factors, such as exist for isolated bacteria within extracellular tissue matrices.
In summary, the potential of group A streptococci to inactivate serum chemotactic activity is mediated by a surface-bound protease that exhibits a high degree of specificity for the C5a chemotaxin. The recognized role of C5a in complement-mediated inflammatory responses (7, 8) and the association of SCFI with virulent strains (11) suggests that it might be a virulence factor for this organism. Knowledge of how SCFI contributes to microbial virulence in vivo and identification of factors with comparable activity in other systems will further define strategies evolved by microorganisms to circumvent mechanisms of host defense.
